Vickesh Myer is CTO at Editas Medicine, Inc. (EDIT). They have made 10 open-market trades across 1 company since 2018, most recently 2019-03-18.
CIK 0001742806
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EDIT | 3,000 | $7K |
Shares reported on the most recent Form 4, priced at the 2019-03-20 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EDIT | SELL | 2019-03-18 | 2019-03-20 | $24.50 | $74K | +3.8% | +10.6% | -3.4% |
| EDIT | SELL | 2019-02-20 | 2019-02-22 | $20.42 | $123K | +6.6% | +7.4% | -0.2% |
| EDIT | SELL | 2019-01-17 | 2019-01-18 | $26.36 | $185K | -7.6% | -14.0% | +9.7% |
| EDIT | SELL | 2018-12-17 | 2018-12-19 | $27.61 | $193K | -5.7% | +5.7% | -2.5% |
| EDIT | SELL | 2018-11-19 | 2018-11-21 | $27.23 | $191K | +11.0% | -33.8% | -26.4% |
| EDIT | SELL | 2018-10-17 | 2018-10-19 | $29.20 | $204K | -8.1% | -1.5% | -4.9% |
| EDIT | SELL | 2018-09-17 | 2018-09-19 | $32.23 | $355K | -8.5% | -17.4% | -21.0% |
| EDIT | SELL | 2018-08-17 | 2018-08-21 | $29.78 | $208K | +5.1% | +4.3% | -13.1% |
| EDIT | SELL | 2018-07-17 | 2018-07-19 | $35.46 | $603K | -17.4% | -15.5% | -17.9% |
| EDIT | SELL | 2018-06-18 | 2018-06-20 | $38.26 | $536K | -9.8% | -11.6% | -20.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.